Rifandine

利福定

Report date: 2025/07/16 14:28:46
NME

Base Information

Drug NameRifandine
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsPyodermaTuberculosis, PulmonaryTuberculosis, Cutaneous +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsPyodermaTuberculosis, PulmonaryTuberculosis, Cutaneous +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A